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The most attractive properties of nanomaterials
for medical and technologic applications,
including their small size, large surface area,
and high reactivity, are also the main factors for
their potential toxicity (reviewed by Donaldson
et al. 2001; Oberdörster et al. 2005). Based on
inhalation studies with ambient ultraﬁne parti-
cles, it has been predicted that nanosized parti-
cles will have higher pulmonary deposition and
biological activity compared with larger parti-
cles (reviewed by Oberdörster et al. 2005).
Thus, some nanosized materials may induce
not only damage at the deposition site but also
distant responses as a result of their transloca-
tion and/or reactivity throughout the body
(Oberdörster et al. 2005). In this respect, epi-
demiologic and experimental studies have sug-
gested an association between respiratory
exposure to ambient ultraﬁne particles (includ-
ing particles with a diameter < 100 nm) and
the progression of cardiovascular disease
(reviewed by Brook et al. 2004).
Engineered carbon nanomaterials, includ-
ing carbon nanotubes, have elicited a great deal
of interest recently because of their unique elec-
tronic and mechanical properties. Single-wall
carbon nanotubes (SWCNTs) have a diameter
ranging from 0.7 to 1.5 nm, with lengths
> 1 µm. Initial toxicologic studies demon-
strated that intratracheal or pharyngeal instilla-
tion of SWCNT suspension in mice caused a
persistent accumulation of carbon nanotube
aggregates in the lung, followed by the rapid
formation of pulmonary granulomatous and
fibrotic tissues at the site (Lam et al. 2004;
Shvedova et al. 2005). The unique physical
characteristics and the pulmonary toxicity of
SWCNTs raised concerns that respiratory
exposure to these materials may be associated
with systemic toxicities. In the present studies,
we demonstrate that lung instillation of
SWCNT is associated with a dose-dependent
increase in oxidative vascular damage mani-
fested by heme oxygenase (HO)-1 gene activa-
tion and mitochondrial alterations. Because
these types of oxidative modiﬁcations are con-
sidered to play a role in atherogenesis, we fur-
ther evaluated the effects of SWCNT
respiratory exposure on atherosclerosis progres-
sion in ApoE–/– transgenic mice, a widely used
model of human atherosclerosis.
Materials and Methods
Animals. Male FVB/N-TgN (Ho1-luc) Xen
mice were obtained from Xenogen Corp.
(Alameda, CA). These mice carry a fusion of
a 15-kb mouse HO-1 promoter with modi-
ﬁed ﬁreﬂy luciferase cDNA (Promega pGL-3)
and were used to assess HO-1 activation.
Male C57BL/6J and B6.129P2-Apoetm1Unc
(ApoE–/–) mice were obtained from Jackson
Laboratory (Bar Harbor, ME). The ApoE–/–
mice lack apolipoprotein E (a high-afﬁnity lig-
and for lipoprotein receptors), consequently
have elevated plasma levels of cholesterol and
triglycerides, and develop atherosclerotic
plaques in a fashion similar to humans
(Reddick et al. 1994). Mice were between
2 and 3 months of age when exposures began,
and were fed an irradiated commercial mouse
chow diet (LM-485; Harlan, Indianapolis,
IN). For some of the atherosclerosis studies,
ApoE–/– mice were fed a high fat diet (15.8%
fat; TD 88051; Harlan), which exacerbates
the atheroma formation. All mice were pro-
vided tap water ad libitum and were housed in
ventilated cages on autoclaved hardwood chip
bedding. Sentinel mice were free of endoge-
nous pathogens. Animal room conditions
included HEPA-filtered air, controlled tem-
perature and humidity, and a 12-hr light/dark
cycle. Animal care and use procedures, includ-
ing sacriﬁce by carbon dioxide asphyxiation,
were conducted in accordance with the Public
Health Service Policy on Humane Care and Use
of Laboratory Animals (Office of Laboratory
Animal Welfare 2002) and the Guide for the
Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources 1996); these
procedures were approved by the National
Institute for Occupational Safety and Health
institutional animal care and use committee.
All mice used in these studies were treated
humanely and with regard for alleviation for
suffering. 
General experimental design. To screen for
systemic oxidative effects of SWCNT expo-
sure, Ho1-luc reporter mice or C57BL/6 mice
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BACKGROUND: Engineered nanosized materials, such as single-wall carbon nanotubes (SWCNT),
are emerging as technologically important in different industries. 
OBJECTIVE: The unique physical characteristics and the pulmonary toxicity of SWCNTs raised con-
cerns that respiratory exposure to these materials may be associated with cardiovascular adverse
effects. 
METHODS: In these studies we evaluated aortic mitochondrial alterations by oxidative stress assays,
including quantitative polymerase chain reaction of mitochondrial (mt) DNA and plaque formation
by morphometric analysis in mice exposed to SWCNTs.
RESULTS: A single intrapharyngeal instillation of SWCNTs induced activation of heme oxygenase-1
(HO-1), a marker of oxidative insults, in lung, aorta, and heart tissue in HO-1 reporter transgenic
mice. Furthermore, we found that C57BL/6 mice, exposed to SWCNT (10 and 40 µg/mouse),
developed aortic mtDNA damage at 7, 28, and 60 days after exposure. mtDNA damage was accom-
panied by changes in aortic mitochondrial glutathione and protein carbonyl levels. Because these
modiﬁcations have been related to cardiovascular diseases, we evaluated whether repeated exposure
to SWCNTs (20 µg/mouse once every other week for 8 weeks) stimulates the progression of ather-
osclerosis in ApoE–/– transgenic mice. Although SWCNT exposure did not modify the lipid proﬁles
of these mice, it resulted in accelerated plaque formation in ApoE–/– mice fed an atherogenic diet.
Plaque areas in the aortas, measured by the en face method, and in the brachiocephalic arteries,
measured histopathologically, were significantly increased in the SWCNT-treated mice. This
response was accompanied by increased mtDNA damage but not inﬂammation.
CONCLUSIONS: Taken together, the ﬁndings are of sufﬁcient signiﬁcance to warrant further studies
to evaluate the systemic effects of SWCNT under workplace or environmental exposure paradigms. 
KEY WORDS: atherosclerosis, inﬂammatory cytokines, mitochondrial DNA damage, nanomaterials,
nanotoxicology, oxidative stress. Environ Health Perspect 115:377–382 (2007). doi:10.1289/ehp.9688
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SWCNT in doses of 10–40 µg/mouse by sin-
gle intrapharyngeal instillation and were sacri-
ficed at time points including 1, 7, 28, and
56 days after exposure. These experimental set-
tings were selected to correspond to previous
pulmonary toxicity studies (Shvedova et al.
2005). Pulmonary toxicity has been character-
ized with early but acute and transient inﬂam-
matory response, granuloma formation around
SWCNT agglomerates, and a fibrogenic
response. To evaluate SWCNT effects on
atherosclerosis progression, a chronic process,
ApoE–/– mice (10/treatment) were exposed by
pharyngeal aspiration to a medium dose of
SWCNT (20 µg/mouse) via multiple expo-
sures (once every other week for 8 weeks). In
all studies the control animals were exposed by
pharyngeal aspiration to vehicle [sterile phos-
phate-buffered saline (PBS)].
Particles and particulate instillation.
SWCNT (CNI, Houston, TX) were pro-
duced by the high pressure carbon monoxide
proportionation process (HiPco) technique
(Scott et al. 2003; Scott and Smalley 2003)
and purified by acid treatment to remove
metal contaminants (Gorelik et al. 2000).
Their physicochemical characteristics, includ-
ing chemical content, mean diameter, and
surface area, were reported previously
(Shvedova et al. 2005). Ultraﬁne carbon black
(UfCB) particles (Printex 90, Degussa,
Germany), used as a control material, were a
gift from G. Oberdörster (University of
Rochester, Rochester, NY). Suspensions of
SWCNTs and UfCBs were prepared by soni-
fication using a Branson Sonifier 450
(Branson Ultrasonics Corp., Danbury, CT)
in PBS for 3 min (at 400 W) at room temper-
ature before animal exposure. For particulate
administration, we used the pharyngeal aspi-
ration technique (Rao et al. 2003). Briefly,
mice were anesthetized with isoflurane
(Abbott Laboratories, North Chicago, IL)
and placed on a slant board, and the tongue
was gently held in full extension while a
60-µL suspension of particles was pipetted
onto the base of the tongue. This technique
provides for a wide dissemination of particles
in a peribronchiolar pattern within the alveo-
lar region (Rao et al. 2003). 
Tissue and blood collection. Food was
removed from the cage for ~ 8 hr before sacri-
fice. Whole blood samples were drawn from
the inferior vena cava into EDTA-containing
tubes. The plasma was collected and stored
for later analysis. The heart and vascular tree
were perfused with ice-cold PBS containing
heparin (10 U/mL) for the atherosclerotic
lesion analysis. Animals used for evaluation of
oxidative stress were perfused with ice-cold
PBS containing 20 mM butylated hydroxy-
toluene (BHT) to prevent further oxidation.
For DNA damage studies, the aortas were
retrieved and rapidly frozen in liquid nitrogen
and stored at –80°C before analysis. For
histopathologic studies, the aorta and heart
were harvested and stored in buffered forma-
lin (10%), or the brachiocephalic artery
(BCA) was dissected and snap-frozen in
Tissue-Tek OCT-compound (Sakura
Finetek, Torrance, CA) to be used for cryo-
stat sections. 
Measurement of luciferase activity. Pieces
(10 mg each) of lung, heart, and aorta from
Ho1-luc mice were removed, placed in 0.2 mL
tissue lysis buffer (Promega, Madison, WI),
chopped into ﬁne pieces, and left overnight at
4°C on a shaker. After brief centrifugation,
supernatants of the tissue lysates were collected
and luciferase activity was measured using a
commercial kit (Promega) and a MicroLumat
Plus LB 96V luminometor (EG&G Berthold,
Bad-Wildbad, Germany). 
Quantitative polymerase chain reaction
(QPCR) for evaluating mitochondrial (mt)
DNA damage. The QPCR assay, which evalu-
ates the average lesion frequency per strand for
the two template strands in the segment of
interest, was conducted according to a protocol
described previously (Ballinger et al. 1999,
2000) with slight modifications. Briefly,
genomic DNA was isolated using the Qiagen
genomic tip 20G kit (Qiagen Inc., Valencia,
CA). The DNA concentration was measured
using the PicoGreen dsDNA quantitation kit
(Molecular Probes, Eugene, OR). QPCR of
extra long amplification product was carried
out using the Expand 20 kb PCRplus System
(Roche, Mannheim, Germany). A mouse
12-kb mtDNA fragment was ampliﬁed using
the following primers: F5´-AGAGAT-
TTCTCTACACCTTCGAATTTGC-3´ and
R5´-ATTTAATTTGAGGGTGA-
CGGGCGG-3´. The PCR reaction system
contained 100 ng DNA as a template.
Amplification consisted of an initial cycle of
denaturation (92°C, 2 min) followed by
25 cycles of denaturation (92°C, 30 sec),
annealing (65°C, 30 sec), and extension (68°C,
15 min), with a ﬁnal extension (68°C, 10 min)
cycle. A short (180 bp) fragment from the
D-loop part of mtDNA was amplified using
the following primers: F5´-TAATCAGCC-
CATGACCAACA-3´ and R5´-GATTGGG-
TTTTGCGGACTAA-3´. Ten microliters of
PCR products were applied to gel elec-
trophoresis (0.8% agarose gel, 75 V, 1 hr).
Gels were stained by ethidium bromide,
imaged using the Alphaimager System (Alpha
Innotech Corp., San Leandro, CA), and quan-
tiﬁed by scanning laser densitometry.
Aortic mitochondria isolation. Mito-
chondria were isolated from fresh aortas by dif-
ferential centrifugation (Young et al. 2005).
Brieﬂy, tissues were homogenized in isotonic
buffer containing 10 µg/mL protease inhibitors
(aprotinin, phenylmethylsulphonylfluoride,
leupeptin, sodium orthovanadate) and BHT
(5 mM) at 4°C. Tissue homogenates were cen-
trifuged at 1,500 × g and 4°C for 15 min, and
the supernatants were collected. The super-
natants were centrifuged at 10,000 × g for
30 min at 4°C, and the mitochondria were col-
lected in the pellet. Mitochondrial protein con-
centration was measured in BSA-free isolation
buffer by a Lowry Assay (Bio-Rad Corp.,
Hercules, CA). Samples were stored at –70°C. 
Mitochondrial oxidative stress assays.
Mitochondrial reduced glutathione/oxidized
glutathione (GSH/GSSG) ratios were meas-
ured by a Bioxytech GSH/GSSG-412 colori-
metric assay kit (OxisResearch, Portland, OR)
with minor modifications. Briefly, 10 µL
1-methyl-2-vinylpyridinium triﬂuoromethane-
sulfonate was added to scavenge for GSH dur-
ing the mitochondrial isolation. The reaction
mixture was added to a 96-well microtiter plate
at a volume of 50 µL and incubated at room
temperature for 5 min. NADPH was added to
each well, and the change in absorbance at
412 nm was recorded in a microplate reader
(Molecular Device, Sunnyvale, CA) for 3 min.
GSH and GSSG levels were normalized to
protein concentrations and the GSH/GSSG
ratio was calculated. Mitochondrial carbonyl
groups were detected by slot blot (Amersham
Biosciences, Piscataway, NJ). Briefly, 10 µL
mitochondrial protein was derivatized with
2,4-dinitrophenylhydrazine and blotted to
polyvinylidene ﬂuoride membrane (Amersham
Biosciences, Piscataway, NJ). The dirivatized
carbonyl groups, detected by rabbit anti-dini-
trophenol (1:500; Molecular Probes) and
horseradish peroxide–conjugated anti-rabbit
IgG (1:1,000) were visualized by an ECL
system (Amersham, Piscataway, NJ). Band
densities were quantified by densitometry
(ImageQuant, Molecular Dynamics). 
Quantiﬁcation of atherosclerosis. We deter-
mined the extent of aortic atherosclerotic
lesions by the en face method, as described pre-
viously (Simeonova et al. 2003). Briefly, the
aorta was ﬁxed in 10% neutral buffered forma-
lin, opened longitudinally, and stained with
Sudan IV. Aorta images were captured with a
Li et al.
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Figure 1. Time course of HO-1 activation in the lung
and cardiovascular system of Ho1-luc reporter
mice exposed to SWCNTs (40 µg) or vehicle (PBS).
The results are presented as a fold change in the
luciferase activities of the tissue from SWCNT-
exposed mice compared with the respective tissue
from PBS-exposed mice. Each value represents
the mean ± SE of ﬁve mice.
*p < 0.05. Sony DXC-960MD three-chip-coupled
device color video camera (Sony, Tokyo,
Japan), connected to an Olympus SZX12 dis-
section microscope (Olympus, Melville, NY).
Among the individual segments of the same
aorta, the smallest coefficient of variation
occurred in the segment that contained the
most extensive lesions (Palinski et al. 1994);
thus the thoracic part of the aorta was used
for quantitative assessment. Quantitative
analysis of the lesion size was performed using
a Simple PCI C-imaging system (Compix
Inc., Cranberry Township, PA).
Plaque formation in brachiocephalic arter-
ies was quantified as described by Teupser
et al. (2003). Briefly, BCAs were sectioned
from distal to proximal at a 10-µm thickness.
Atherosclerotic lesions luminal to the internal
elastic lamina were quantiﬁed in eight equidis-
tant oil red O–stained sections 200, 300, 400,
500, 600, 700, and 800 µm from the branch-
ing point of the BCA into the carotid and sub-
clavian arteries. The images were captured by
a Sony DXC-960MD three-chip-coupled
device color video camera (Sony) connected to
an Olympus AX70 microscope (Olympus) and
analyzed by Simple PCI C-imaging system
(Compix Inc., Sewickley, PA). For immunos-
taining analysis, we applied specific rat anti-
mouse monoclonal antibodies for Mac-3 (a
marker of monocytes/macrophages) and vascu-
lar cell adhesion molecule 1 (VCAM-1) (both
from BD PharMingen, San Diego, CA) in an
immunostaining protocol conducted on ace-
tone-ﬁxed transverse cryosections; the positive
staining was evaluated as described previously
(Warren et al. 2005).
Plasma cytokine levels. Analysis of cytokines
from plasma samples was conducted using a
mouse inﬂammation cytometric bead array kit
and a FACSCalibur ﬂow cytometer (both from
BD Biosciences, San Diego, CA) following the
manufacturer’s instructions. Standard curves
were determined for each cytokine from the
range of 20–5,000 pg/mL. The lower detec-
tion limit of the assay is 2.5–52.7 pg/mL,
depending on types of cytokines. The follow-
ing cytokines were measured: interleukin-6
(IL-6), monocyte chemoattractant protein-1
(MCP-1), interferon-γ (IFN-γ), tumor necrosis
factor-α (TNF-α), and IL-12.
Statistical analysis. All experiments
were replicated, and representative findings
are shown. Differences among treatment
groups were detected by analysis of variance.
Differences in which the p-value was < 0.05
were considered statistically signiﬁcant. When
signiﬁcant differences were detected, post hoc
comparisons between treatment groups were
examined with the Holm-Sidak method. 
Results
HO-1 activation in cardiovascular tissue. We
conducted initial screening for extrapulmonary
effects using Ho1-luc reporter transgenic mice.
To evaluate HO-1 gene expression, a surrogate
biomarker of oxidative stress (Prawan et al.
2005; Rao et al. 2003), we measured the acti-
vation of tissue luciferase in Ho1-luc reporter
transgenic mice. HO-1 demonstrated a trend
for activation in the lung, aorta, and heart tis-
sue 7 days after SWCNT exposure; the activity
declined approximately to control levels by
28 days after exposure (Figure 1). 
Aortic mitochondrial oxidative damage.
Furthermore, we conducted specific evalua-
tion of vascular oxidative perturbations in
C57BL/6 mice. Because circular mtDNA is
highly susceptible to oxidative damage and
mtDNA damage has been suggested as an
initiating event in atherogenesis (Ballinger
et al. 2000, 2002), we assessed whether
pulmonary SWCNT exposure induces aortic
mtDNA damage. Significant reduction in
mtDNA ampliﬁcation, reﬂecting an increase
in mtDNA damage, was observed in the aortic
tissue of C57BL/6 mice exposed to SWCNT
(10 and 40 µg/mouse) at days 7, 28, and 60
after a single exposure, compared with age-
matched, vehicle-treated control mice
(p < 0.01) (Figure 2A). Maximum mtDNA
damage occurred 7 days after exposure in both
treatment groups and persisted in the high-
dose treatment group 60 days after exposure.
Amplification of a small fragment of the
D-loop of the mitochondrial genome
(Figure 2A), as well as nuclear 18S rRNA
(data not shown), was not affected by the
exposure. Accordingly, the amplification of
the large mtDNA fragment was normalized to
the amplification of the small fragment. In
contrast to SWCNT, UfCB pharyngeal instil-
lation did not result in mtDNA damage in the
aortic tissue at comparable doses of exposure
(Figure 2B).
Changes in mitochondrial GSH levels are
also manifestations of oxidative stress (Suliman
et al. 2004). The aortic mitochondrial
GSH/GSSG ratios were signiﬁcantly reduced
7 days after pulmonary exposure to a single
high dose of SWCNT (Figure 3A). Oxidative
stress also may lead to oxidation of amino acid
residues on proteins, forming protein carbonyls
(Dalle-Donne et al. 2003). Consistently, sig-
niﬁcant accumulation of aortic mitochondrial
protein carbonyl groups occurred in SWCNT-
exposed mice compared with the age-matched
vehicle-exposed mice at both exposure levels
(p < 0.05) (Figure 3B). 
Atherosclerosis evaluation in ApoE–/– mice.
The effects of pulmonary SWCNT exposure
on atherosclerosis development were evaluated
in ApoE–/– mice. ApoE–/– mice were exposed
Single-wall carbon nanotubes and cardiovascular effects
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Figure 2. Aortic mtDNA damage in C57BL/6 mice exposed to SWCNTs shown as representative gel images of the long (12 kb) and short fragment (0.18 kb) mtDNA
ampliﬁcation products and quantitative analyses of the mtDNA damage (a reduction in the ampliﬁcation) presented as a fold difference between each SWCNT-
treated group and the vehicle-treated group. (A) Mice were treated with SWCNTs (0, 10, or 40 µg) and aortas were collected at 7, 28, and 60 days postexposure.
(B) Mice were treated with SWCNTs (0, 20, or 40 µg) or UfCBs (0, 20, or 40 µg) and aortas were collected 60 days postexposure. The 12 kb mtDNA expression was
normalized to 0.18 kb mtDNA expression. Each value represents the mean ± SE of four mice.
**p < 0.01. chronically to PBS or SWCNT (four instilla-
tions of SWCNT at 20 µg/mouse every other
week for 8 weeks) and fed a regular chow diet
(regimen 1) or a fat chow diet for 4 weeks, fol-
lowed by regular chow for 4 weeks (regi-
men 2). Vehicle-exposed ApoE–/– mice on
regimen 1 had lower plasma cholesterol
(p ≤ 0.01) and minimal plaque occurrence in
the aorta compared with the mice on
regimen 2. The body weights, as well as plasma
cholesterol, glucose, and lactate dehydrogenase
(LDH) levels were comparable in SWCNT-
and vehicle-exposed mice under both diet regi-
mens (Table 1). Plaque formation, although
appearing slightly increased after exposure to
SWCNT, compared with the vehicle exposure
in mice on regimen 1, was not quantified
because the size of the plaques was not large
enough for meaningful analysis or comparisons
to be made (representative images presented in
Figure 4A). However, in mice on regimen 2,
the aortic morphometric en face analysis
demonstrated a significant increase in the
plaque areas in SWCNT-exposed mice com-
pared with the vehicle-treated mice (p < 0.05)
(Figure 4B, C). Histologic assessment of the
lesion size in the BCAs of these mice con-
firmed that SWCNT exposure accelerated
atherosclerosis progression (Figure 5). The
BCA was quantified at seven sections: 200,
300, 400, 500, 600, 700, and 800 µm
proximal from its branching site into the
carotid and subclavian arteries. SWCNT
exposure was associated with considerably
larger atherosclerotic lesion area at each BCA
location examined (representative images
shown in Figure 5A). The overall lesion area
of the BCA was significantly higher in
the SWCNT-exposed mice than in the
PBS-treated mice (mean ± SE, 447,239 ±
164,242 µm2 and 192,911 ± 90,755 µm2,
respectively; p < 0.001; Figure 5B). 
To assess the inﬂuence of SWCNT expo-
sure on inflammatory characteristics of the
plaque, serial sections of the BCA were
immunostained with antibodies to Mac-3
(Ralph et al. 1983) and VCAM-1 (Matheny
et al. 2000). Consistent with the larger size of
the plaques, the number of macrophages and
VCAM-1–positive cells were proportionally
higher in the BCA plaques from SWCNT-
exposed mice compared with plaques in PBS-
treated mice (Figure 5C, D). In the evaluated
sections, we found no evidence that SWCNT
exposure resulted in increased immunostain-
ing in the vascular wall, which was not
affected by plaque formation. 
We also evaluated the involvement of sys-
temic inﬂammation and aortic mtDNA dam-
age in SWCNT-related atherosclerosis
progression. The plasma MCP-1, IL-12, IL-6,
TNF-α, and IFN-γ levels were not signiﬁcantly
different in ApoE–/– mice treated with PBS or
SWCNT (Figure 6A). However, the aortas of
SWCNT-exposed ApoE–/– mice demonstrated
signiﬁcantly increased mtDNA damage.
Discussion
These studies demonstrate that SWCNTs,
under the described conditions, have the
potential to inﬂuence cardiovascular diseases.
The effects were manifested as distressed
mitochondrial homeostasis represented by
mtDNA damage, GSH depletion, and
increased protein carbonyl formation in aortic
tissue. Mitochondrial components have been
reported to be highly susceptible to oxidative
stress, mediated by metabolic defects and
Li et al.
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Figure 3. Oxidative modifications in aortic mito-
chondria freshly isolated from C57BL/6 mice
treated with SWCNTs (0, 10, or 40 µg) 7 days post-
exposure. (A) GSH/GSSG ratio of aortic mitochon-
dria. (B) Protein carbonyl groups in the aortic
mitochondrial proteins (10 µg) shown by represen-
tative dot blot images and densitometric analysis.
The results are presented as a fold change in the
aortic protein carbonyl levels of SWCNT-exposed
mice compared with PBS-exposed mice. Each
value represents the mean ± SE of four mice. 
*p < 0.05. **p < 0.01. 
Table 1. Body weight (BW), plasma cholesterol, triglyceride, glucose, and LDH in ApoE–/– mice exposed to
PBS or SWCNT (four instillations of SWCNT at 20 mg/mouse every other week for 8 weeks) and fed
regimen 1 or regimen 2 diets. 
Regimen Treatment Start BW End BW Total cholesterol Triglyceride Glucose LDH
1 PBS 25.9 ± 0.17 25.2 ± 0.76 606 ± 68 131 ± 27 340 ± 24 142 ± 39
SWCNT 24.3 ± 0.20 25.0 ± 0.56 628 ± 69 131 ± 25 351 ± 36 114 ± 4
2 PBS 19.8 ± 0.57 23.7 ± 0.84 1,541 ± 336** 122 ± 15 271 ± 17 413 ± 40**
SWCNT 20.8 ± 0.79 23.7 ± 0.72 1,674 ± 157** 70 ± 8 266 ± 10 318 ± 23**
Each value represents the mean ± SE of four mice per group. 
**p < 0.01 compared with regimen 1 and the same respiratory treatment. 
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Figure 4. Atheroma formation in the aortas of
ApoE–/– mice repeatedly exposed to SWCNTs
(20 µg/mouse every other week for 8 weeks).
Photomicrographs of representative Sudan IV-
stained thoracic aortas of mice on regimen 1
(A) and regimen 2 (B). (C) Morphometric analysis of
the atherosclerotic lesions in the thoracic aortas of
mice fed on regimen 2. Each value represents the
mean ± SE of 10 mice. 
*p < 0.05. Single-wall carbon nanotubes and cardiovascular effects
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environmental insults (Madamanchi et al.
2005), and mitochondrial dysfunction is
emerging as an important pathophysiologic
factor in a number of cardiovascular diseases
including atherosclerosis (Binkova et al.
2001). Oxidative alterations of mitochondria
result in compromised metabolic processes,
such as oxidative phosphorylation, which can
trigger endothelial dysfunction, a leading
mechanism in atherosclerosis progression
(Choksi et al. 2004). Altered endothelial
activities lead to a series of events including
vasoconstriction, increased adhesiveness
resulting in inﬂammatory cell inﬁltration, and
platelet-thrombus formation (Cai and
Harrison 2000; Libby 2000a, 2000b).
Combination of multiple cardiovascular risk
factors that work through similar processes,
such as mitochondrial dysfunction, may lead
to synergistic acceleration of atherosclerosis
progression and precipitation of its complica-
tions. Consistently, atherosclerosis was accel-
erated in SWCNT-exposed ApoE–/– mice
primed with a high-fat diet. Although
SWCNT-exposed ApoE–/– mice did not have
altered lipid profiles, they had exacerbated
plaque development in the aorta and BCAs.
In addition to the well-established cardio-
vascular risk factors, such as high cholesterol
levels, diabetes mellitus, and hypertension,
many nontraditional risk factors, including
concomitant infections, systemic autoimmune
diseases, and arsenic exposure, have been sug-
gested to inﬂuence atherosclerotic process and
precipitate disease complications (Libby
2000b; Ross 1999; Simeonova and Luster
2004). In this respect, epidemiologic and
experimental studies have recently found a
positive association between air pollution (i.e.,
ultrafine particulates) and adverse cardio-
vascular outcomes, particularly in high risk
individuals such as those with preexisting
chronic pulmonary or cardiovascular diseases
(Brook et al. 2004; Künzli et al. 2005; Peters
et al. 2004; Pope et al. 2004). Consistently,
hyperlipidemic rabbits exposed to PM10 (par-
ticulate matter ≤ 10 µm in aerodynamic diam-
eter) or ApoE–/– mice exposed to PM2.5
(≤ 2.5 µm ) develop advanced coronary and/or
aortic atherosclerosis (Chen and Nadziejko
2005; Sun et al. 2005). Evidence from human
and toxicologic exposure studies suggest that
oxidative stress and inflammation is most
likely involved in particle-mediated cardiovas-
cular effects (Barclay et al. 2005; Brook et al.
2004; Sun et al. 2005). Although the role of
mitochondrial distress in atherosclerosis
related to respiratory particle exposure has not
been well explored, cigarette smoke and
hypercholesterolemia have been shown to
result in mtDNA damage and greater plaque
formation (Knight-Lozano et al. 2002). 
Pulmonary exposure to SWCNTs may
induce cardiovascular effects either directly or
indirectly through mitochondrial oxidative
perturbations, which can result in altered ves-
sel homeostasis. SWCNT-induced lung
pathophysiologic responses are associated with
deposition of particle agglomerates and
histopathologic alterations in the lung.
Hypothetically, it is possible that individual
SWCNTs can translocate from the lung into
the systemic circulation causing direct cardio-
vascular endothelial dysfunction. It has been
reported that nanoparticles treated with
albumin and/or surfactant proteins cross the
alveolo-capillary barrier to gain access to the
systemic circulation (Kato et al. 2003;
Oberdörster et al. 2005). The proximity
between epithelial type I and endothelial cell
caveolar membrane structures might play a role
in the particle translocation mechanisms
(Heckel et al. 2004). Because SWCNTs are
not well recognized and cleared by lung
macrophages (Kagan et al. 2006; Shvedova
et al. 2005), nanotubes, dispersed or disinte-
grated from the agglomerates, may persist in
the alveolar space, which will facilitate their
access into the systemic circulation. In contrast
to SWCNTs, a similar dose of UfCB agglom-
erated particles, which are readily phagocytized
by alveolar macrophages, did not produce lung
ﬁbrosis or granulomas (Shvedova et al. 2005)
or induce cardiovascular mtDNA damage. It is
also possible that indirect processes are respon-
sible for the cardiovascular effects induced by
SWCNT exposure. This could occur if either
mediators, released from the lung into the sys-
temic circulation, or hypoxemia, associated
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Figure 5. Atheroma formation in the BCA of ApoE–/– mice repeatedly exposed to SWCNTs (20 µg/mouse
every other week for 8 weeks) and fed regimen 2. (A) Representative images of oil red O–stained serial
sections of BCA. (B) Quantiﬁcation analysis of the atherosclerotic lesions in seven sections of BCA (200,
300, 400, 500, 600, 700, and 800 µm proximal from its branching site into the carotid and subclavian arter-
ies). (C) Images of representative BCA sections immunostained for Mac-3 and VCAM-1; the arrow indi-
cates positive immunostaining. (D) Quantiﬁcation analysis of the immunostained sections. For (B) and (D),
each value represents the mean ± SE of 10 mice. 
*p < 0.05. #p < 0.001. 
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Figure 6. Evaluation of systemic inflammation and
aortic mitochondrial DNA damage in ApoE–/– mice
repeatedly exposed to SWCNTs (20 µg/mouse every
other week for 8 weeks) and fed regimen 2.
(A) Plasma levels of MCP-1, IL-12, IL-6, TNF-α, and
INF-γ (pg/mL); each value represents the mean ± SE
of 10 mice. (B) Representative gel images of the long
(12 kb) and short (0.18 kb) fragment mtDNA ampliﬁ-
cation products and quantitative analyses of the
mtDNA damage presented as a fold difference
between the SWCNT-treated group and the vehicle-
treated group. The 12-kb mtDNA expression was
normalized to 0.18-kb mtDNA expression; each value
represents the mean ± SE of 4 mice. 
**p < 0.01. with altered pulmonary function seen after
SWCNT exposure (Shvedova et al. 2005),
lead to oxidative modiﬁcations and low-level
systemic inﬂammation. In the present study,
several inﬂammatory mediators known to play
a role in atherosclerosis were measured in the
ApoE–/– mice evaluated for the atherosclerotic
lesions. Although SWCNT exposure was asso-
ciated with atherosclerosis acceleration, we did
not observe significant differences in the
plasma levels of IL-6, IL-10, MCP-1, TNF-α,
or IFN-γ. Furthermore, SWCNT exposure
was not related to increased inﬂammation in
the vascular wall before formation of the
plaques. A third hypothesis for SWCNT
exposure–mediated cardiovascular effects is
through platelet activation in the lung circula-
tion. The pulmonary circulation is considered
a site for platelet formation (Martin et al.
1983; O’Sullivan and Michelson 2006), and it
has been demonstrated that SWCNT can
directly activate platelet aggregation in vitro
(Radomski et al. 2005). Furthermore, trans-
forming growth factor-β1(TGF−β1), which is
involved in platelet activation (Hoying et al.
1999), has been found to be significantly
increased in the lung of SWCNT-treated mice
(Shvedova et al. 2005), and the time course of
its increase paralleled the occurrence of cardio-
vascular mitochondrial dysfunction. Although
a link between activated platelets and cardio-
vascular mitochondrial distress has not been
clearly established, it is well understood that
that both platelet activation and mitochondrial
damage lead to endothelial dysfunction and
atherosclerosis (Ballinger 2005; Ross 1993). 
Overall, these initial studies demonstrate
that respiratory exposure to high concentrations
of mostly agglomerated SWCNTs provokes
not only pulmonary toxicity but vascular effects
related to mitochondrial oxidative modifica-
tions and accelerated atheroma formation.
Taken together, the ﬁndings are of sufﬁcient
signiﬁcance to warrant further studies to evalu-
ate the systemic effects of SWCNTs under
inhalation exposure paradigms more likely to
occur in the workplace or environment, such as
low-level chronic inhalation exposure. Studies
in progress involving labeled SWCNTs, as well
as detailed analysis of the role of lung platelet
activation, will provide more insight into the
mechanisms of the cardiovascular mitochon-
drial dysfunction in SWCNT-treated animals. 
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